[The treatment and prevention of premenopausal uterine hemorrhages with Trisequens].
The authors describe the results from 30 women with premenopausal uterine bleedings and accompanying neuro-autonomic climacteric symptoms, treated with the combined estrogestagenic preparation (Trisequens--Novo Nordisk A/S). The mean age of the contingent is 47.64 years. The clinical characteristics of pseudomenstrual function, climacteric symptoms, fatty metabolism and carbohydrate tolerance are examined. Stable pseudomenstrual function, discontinued or sharply reduced climacteric symptoms, lack of substantial changes in the fatty and carbohydrate metabolism are found after treatment. It is necessary that similar treatment could be used considerably more widely in the daily gynecological practice.
Rachev
E
E
Katsarova
M
M
Bŭrdarova
I
I
D002979:Climacteric / Q000187:drug effects; D004338:Drug Combinations; D004341:Drug Evaluation; D004958:Estradiol / Q000627:therapeutic use*; D004964:Estriol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D008598:Menstruation / Q000187:drug effects; D008875:Middle Aged; D009640:Norethindrone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014592:Uterine Hemorrhage / Q000188:drug therapy*
D004338:Drug Combinations; D004958:Estradiol; C032040:Trisequens; D004964:Estriol; D009640:Norethindrone
Lechenie i profilaktika na premenopauzalnite matochni krŭvotecheniia s Trisequens.